AGM/EGMApr 29, 2026, 04:32 PM
GLUE 2026 Annual Meeting Set for June 11
AI Summary
Monte Rosa Therapeutics, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 11, 2026. Shareholders will vote on the election of three Class II director nominees and the ratification of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. The record date for stockholders entitled to vote is April 16, 2026.
Key Highlights
- GLUE's 2026 Annual Meeting of Stockholders will be held virtually on June 11, 2026, at 8:30 a.m. ET.
- Stockholders will vote to elect three Class II director nominees: Andrew Schiff, Chandra Leo, and Anthony Manning.
- Stockholders will also ratify the appointment of Deloitte & Touche LLP as the independent auditor for fiscal year 2026.
- The record date for voting eligibility is April 16, 2026.
- As of April 16, 2026, there were 84,382,573 shares of common stock outstanding.
- Proxy materials are being distributed via the
- notice and access
- approach, with Notice of Availability mailed around April 29, 2026.
Price Impact
More from GLUE